CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-04 | Dethlefs Sven EVP, North America Commercial | Option exercise · Restricted Share Units | −38,538 | 115,617 | ||
| 2023-03-04 | Daniell Richard Exec. VP, European Commercial | Option exercise | +15,921 | 85,691 | ||
| 2023-03-04 | Daniell Richard Exec. VP, European Commercial | Option exercise | +33,512 | 119,203 | ||
| 2023-03-04 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −15,921 | 0 | ||
| 2023-03-04 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −33,512 | 100,536 | ||
| 2023-03-03 | Weiss Amir Chief Accounting Officer | Grant or award · Restricted Share Units | +20,717 | 20,717 | ||
| 2023-03-03 | Stark David Matthew Exec. VP Chief Legal Officer | Grant or award · Restricted Share Units | +94,621 | 94,621 | ||
| 2023-03-03 | Shani Eli EVP,Global Marketing&Portfolio | Grant or award · Restricted Share Units | +59,760 | 59,760 | ||
| 2023-03-03 | Sabag Mark EVP, International Markets | Grant or award · Restricted Share Units | +99,601 | 99,601 | ||
| 2023-03-03 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Grant or award · Restricted Share Units | +199,202 | 199,202 | ||
| 2023-03-03 | Inbar Galia See "Remarks" | Grant or award · Restricted Share Units | +59,760 | 59,760 | ||
| 2023-03-03 | Hughes Eric A See "Remarks" | Grant or award · Restricted Share Units | +99,601 | 99,601 | ||
| 2023-03-03 | Francis Richard D President and CEO | Grant or award · Restricted Share Units | +268,924 | 268,924 | ||
| 2023-03-03 | Drape Eric Executive VP Global Operations | Grant or award · Restricted Share Units | +99,601 | 99,601 | ||
| 2023-03-03 | Dethlefs Sven EVP, North America Commercial | Grant or award · Restricted Share Units | +99,601 | 99,601 | ||
| 2023-03-03 | Daniell Richard Exec. VP, European Commercial | Grant or award · Restricted Share Units | +249,003 | 249,003 | ||
| 2023-02-28 | Weiss Amir Chief Accounting Officer | Option exercise | +3,219 | 27,777.41 | ||
| 2023-02-28 | Weiss Amir Chief Accounting Officer | Option exercise · Restricted Share Units | −3,219 | 3,219 | ||
| 2023-02-28 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +18,430 | 21,404.39 | ||
| 2023-02-28 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −18,430 | $9.89 | $182K | 2,974.39 |
Page 31 of 76 · 1,517 trades